Sharda Cropchem - Outperformance On All Fronts In Q3: Prabhudas Lilladher 

BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

Prabhudas Lilladher Report

Sharda Cropchem Ltd. reported better than expected results driven by strong demand from Europe and North American Free Trade Agreement region and new product introduction.

Pre-buying of raw material in the wake of cost inflation and healthier sales mix aided 985 basis points improvement in gross margins.

The company turned around operations in FY21, leveraging on the demand from Europe & NAFTA.

Growth momentum is expected to continue driven by expanding distribution reach, new launches and strong demand for generic molecules.

Also cushion on gross margins is expected to continue with better availability and healthy demand

Click on the attachment to read the full report:

DISCLAIMER

This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.